Trials / Completed
CompletedNCT00403585
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
A Phase IV, Open Label, Single Arm, Multicenter, Extension Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, single-arm, multi-centre extension study for Korean patients with chronic hepatitis B and compensated liver disease who have completed one-year adefovir dipivoxil treatment in ADF103814. The objective is to assess clinical efficacy and safety of long term (up to 3 years) adefovir dipivoxil 10mg therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | adefovir dipivoxil 10mg |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2006-11-27
- Last updated
- 2010-12-15
- Results posted
- 2010-11-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00403585. Inclusion in this directory is not an endorsement.